Tirbanibulin topical therapy for actinic keratosis
George Martin, MD, with Bob Kronemyer The molecule contained in tirbanibulin 1% ointment (Klisyri; Almirall SA) for treating actinic keratosis of the face and scalp is clearly a game changer, according to George Martin, MD, Medical Director at Dr. George Martin Dermatology Associates in Kihei, Hawaii. “In a pooled analysis of results from phase 3 […]
Minimizing Formulary-Driven Switching
Dr. Brent Moody discusses non-medical switching and formulary exclusions, how they affect both dermatology patients and practices, and what the dermatologist can do to advocate for their patients.
New Developments in Sun Protection
Dr. Henry Lim shares insights into new needs and challenges for protecting the skin from the visible light spectrum. Henry Lim, MD, FAAD, is a board-certified dermatologist, Henry Ford Health System, Detroit, Mich., and former president (2017-2018) of the AAD. Exposure to visible light can cause unwanted skin effects. The problem, says Henry Lim, MD, […]
CBD cream for inflammatory conditions
Michael Milane, MD, MBA, MPH, with John Jesitus Cannabinoids (CBDs) have potential as anti-inflammatory products. Chief among topical CBD’s therapeutic advantages is safety. The size of the market for topical cannabinoids is potentially massive. An Allied Market Research report projects that by 2026, the global CBD skincare market will reach $3.48 billion.1 A pharmaceutical grade […]
From bud to breakthrough
The therapeutic potential and current landscape of cannabinoids in dermatology Adam Friedman, MD, with John Jesitus Presented at Montreal Dermatological Society, February 11, 2021, Montreal, Canada Topical cannabinoids including cannabidiol (CBD) show promise for targeting many inflammatory dermatologic conditions. Although a few such products have begun the path toward FDA approval, much work remains with […]
Literature Lessons
By Ted Rosen, MD, FAAD, Editor-in-Chief Off-label pearl Metformin: a cheap, relatively safe medicationMetformin, either as a stand-alone or as part of a regimen, is beneficial in women with polycystic ovary syndrome (PCOS) who have acne. Dosage required may vary from 500 mg QD to 500 mg TID. This recommendation is based on a meta-analysis […]
The 3 most high-impact cosmetic innovations
Glynis Ablon, MD and Seth Matarasso, MD with Eliza Cabana Innovation is a process of change or transformation. It can be subtle, obvious, or disruptive, or all 3 in the ever-evolving field of cosmetic dermatology. The Dermatology Digest asked 2 recognized experts in cosmetic dermatology to share what they believe the most innovative aesthetic treatments […]